Literature DB >> 12461050

Severe hyponatraemia: investigation and management in a district general hospital.

B O Saeed1, D Beaumont, G H Handley, J U Weaver.   

Abstract

AIMS: To study the incidence, investigation, and management of severe hyponatraemia (serum sodium < 120 mmol/litre) over a period of six months in a district general hospital.
METHODS: The laboratory computer was used to identify all inpatients who had a serum sodium concentration of less than 120 mmol/litre over a six month period. The records of these patients were reviewed for the relevant demographic, clinical, and laboratory data, in addition to diagnosis, treatment, and outcome of hospitalisation.
RESULTS: Forty two patients were studied, with a female to male ratio of 2 : 1. Nine patients had central nervous system symptoms, and four of these patients died in hospital. Only 14 patients had their urinary electrolytes and/or osmolality checked. A diagnosis of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) was mentioned in eight patients, sometimes without checking their urinary electrolytes or osmolality. Twenty one patients died in hospital. The patients who died did not have lower serum sodium values or a higher rate of correction of hyponatraemia, but they all suffered from advanced medical conditions.
CONCLUSIONS: The possible cause of hyponatraemia should always be sought and that will require an accurate drug history, clinical examination, and assessment of fluid volume, plus the measurement of urinary electrolytes and osmolality in a spot urine sample. The diagnosis of SIADH should not be confirmed without the essential criteria being satisfied. The current or recent use of diuretics is a possible pitfall in the diagnosis of SIADH. The rate of serum sodium correction of less than 10 mmol/day is probably the safest option in most cases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461050      PMCID: PMC1769815          DOI: 10.1136/jcp.55.12.893

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

Review 1.  Hyponatraemia.

Authors:  D M Smith; K McKenna; C J Thompson
Journal:  Clin Endocrinol (Oxf)       Date:  2000-06       Impact factor: 3.478

Review 2.  Hyponatraemia and sick cells.

Authors:  C T Flear; C M Singh
Journal:  Br J Anaesth       Date:  1973-09       Impact factor: 9.166

Review 3.  The syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  F C Bartter; W B Schwartz
Journal:  Am J Med       Date:  1967-05       Impact factor: 4.965

Review 4.  Vasopressin function in the syndrome of inappropriate antidiuresis.

Authors:  R Zerbe; L Stropes; G Robertson
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

5.  Hyponatremia.

Authors:  M Goldberg
Journal:  Med Clin North Am       Date:  1981-03       Impact factor: 5.456

6.  Adaptation to chronic hypoosmolality in rats.

Authors:  J G Verbalis; M D Drutarosky
Journal:  Kidney Int       Date:  1988-09       Impact factor: 10.612

7.  The outcome of hyponatremia in a general hospital population.

Authors:  D Baran; T A Hutchinson
Journal:  Clin Nephrol       Date:  1984-08       Impact factor: 0.975

8.  Osmotic demyelination syndrome following correction of hyponatremia.

Authors:  R H Sterns; J E Riggs; S S Schochet
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

9.  Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women.

Authors:  A I Arieff
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

10.  Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin.

Authors:  R J Anderson; H M Chung; R Kluge; R W Schrier
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

View more
  23 in total

1.  The investigation and management of severe hyponatraemia.

Authors:  M Crook
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Results of measurement of urine osmolality and sodium in the evaluation of severe hyponatraemia.

Authors:  P-A Laloë; A Wong; M J Murphy
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

3.  Misinterpretation of serum cortisol in a patient with hyponatraemia.

Authors:  Jamie C Smith; H Siddique; R J M Corrall
Journal:  BMJ       Date:  2004-01-24

Review 4.  Disorders of sodium balance.

Authors:  Rebecca M Reynolds; Paul L Padfield; Jonathan R Seckl
Journal:  BMJ       Date:  2006-03-25

5.  Investigation and management of severe hyponatraemia in a hospital setting.

Authors:  M S B Huda; A Boyd; K Skagen; D Wile; C van Heyningen; I Watson; S Wong; G Gill
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

6.  Hyponatraemic encephalopathy: an unusual stroke mimic.

Authors:  William Wareing; Bhagyashree Dhotore; Karim Mahawish
Journal:  BMJ Case Rep       Date:  2015-01-23

7.  Mortality and serum sodium: do patients die from or with hyponatremia?

Authors:  Arun Chawla; Richard H Sterns; Sagar U Nigwekar; Joseph D Cappuccio
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

8.  Syndrome of inappropriate antidiuretic hormone secretion associated with acute myeloid leukemia with multilineage dysplasia.

Authors:  Shoko Nakayama; Taiji Yokote; Kichinosuke Kobayashi; Yuji Hirata; Toshikazu Akioka; Takuji Miyoshi; Takayuki Takubo; Motomu Tsuji; Toshiaki Hanafusa
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

9.  Bioelectrical impedance analysis is more accurate than clinical examination in determining the volaemic status of elderly patients with fragility fracture and hyponatraemia.

Authors:  K Cumming; G E Hoyle; J D Hutchison; R L Soiza
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

Review 10.  Practical issues for the management of hyponatremia in oncology.

Authors:  Rossana Berardi; Andrea Antonuzzo; Livio Blasi; Roberta Buosi; Vito Lorusso; Maria Rita Migliorino; Vincenzo Montesarchio; Nicoletta Zilembo; Roberto Sabbatini; Alessandro Peri
Journal:  Endocrine       Date:  2018-02-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.